ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
299.000 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
STAT3 |
|
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
299.000 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
299.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
299.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
299.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
JAK1 |
|
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
299.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
299.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
299.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
299.000 |
Evidence |
|
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
GRAP |
GRAP: GRB2-related adapter protein |
297.000 |
Evidence |
|
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
PARD6B |
PARD6B, PAR6B: Partitioning defective 6 homolog beta |
297.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
GRAP |
GRAP: GRB2-related adapter protein |
296.000 |
Evidence |
|
ME2 |
ME2: NAD-dependent malic enzyme, mitochondrial precursor |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
295.000 |
Evidence |
|
HCK |
IPI00029769 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
294.000 |
Evidence |
|
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
293.000 |
Evidence |
|
PSMD10 |
PSMD10: 26S proteasome non-ATPase regulatory subunit 10 |
PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
293.000 |
Evidence |
O
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
293.000 |
Evidence |
O
|
SMC1L1 |
SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos |
SMC1L2 |
SMC1B, SMC1L2: Structural maintenance of chromosomes protein 1B |
291.000 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
289.000 |
Evidence |
|